Kathleen ODonnell - ReWalk Robotics Vice Development
| LFWD Stock | 2.07 0.03 1.43% |
Executive
Kathleen ODonnell is Vice Development of ReWalk Robotics
| Address | 3 Hatnufa Street, Yokneam Illit, Israel, 2069203 |
| Phone | 972 4 959 0123 |
| Web | https://golifeward.com |
ReWalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.2373) % which means that it has lost $0.2373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4966) %, meaning that it created substantial loss on money invested by shareholders. ReWalk Robotics' management efficiency ratios could be used to measure how well ReWalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to -0.54. In addition to that, Return On Capital Employed is expected to decline to -0.48. At present, ReWalk Robotics' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.5 M, whereas Other Assets are forecasted to decline to 0.80.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Daniel Cher | Si Bone | 59 | |
| Jacques Cornet | Profound Medical Corp | 68 | |
| Andres Cedron | Orthofix Medical | 43 | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Irina Ridley | Neuropace | 38 | |
| Julie Andrews | Orthofix Medical | 53 | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Nikolas Kerr | Si Bone | 52 | |
| Lori Ciano | Nevro Corp | 57 | |
| David Caraway | Nevro Corp | 63 | |
| Niamh Pellegrini | Nevro Corp | 57 | |
| Mark Karshner | Orthopediatrics Corp | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Larry Chen | Bioventus | N/A | |
| Shana MBA | Nevro Corp | 51 | |
| Christofer Christoforou | Nevro Corp | 54 | |
| Mathieu Burtnyk | Profound Medical Corp | 42 | |
| Dan Yarbrough | Orthofix Medical | N/A | |
| Michael Pisetsky | Si Bone | 46 | |
| Amy Treadwell | Neuropace | N/A | |
| Meredith Vornholt | Nevro Corp | N/A | |
Management Performance
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.24 |
ReWalk Robotics Leadership Team
Elected by the shareholders, the ReWalk Robotics' board of directors comprises two types of representatives: ReWalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ReWalk. The board's role is to monitor ReWalk Robotics' management team and ensure that shareholders' interests are well served. ReWalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ReWalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Michael Lawless, Chief Officer | ||
| Almog Adar, VP Officer | ||
| Miri Pariente, Regulatory Operations | ||
| Jeannine Lynch, Vice Strategy | ||
| Kathleen ODonnell, Vice Development | ||
| Charles Remsberg, Chief Officer | ||
| Judy Kula, Human Service |
ReWalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ReWalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (1.02) % | ||||
| Operating Margin | (0.66) % | ||||
| Current Valuation | 8.56 M | ||||
| Shares Outstanding | 8.81 M | ||||
| Shares Owned By Insiders | 2.76 % | ||||
| Shares Owned By Institutions | 21.63 % | ||||
| Number Of Shares Shorted | 146.56 K | ||||
| Price To Book | 0.54 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ReWalk Robotics is a strong investment it is important to analyze ReWalk Robotics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ReWalk Robotics' future performance. For an informed investment choice regarding ReWalk Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ReWalk Robotics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade ReWalk Stock refer to our How to Trade ReWalk Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReWalk Robotics. If investors know ReWalk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReWalk Robotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share 2.713 | Quarterly Revenue Growth 4.016 | Return On Assets (0.24) | Return On Equity (0.50) |
The market value of ReWalk Robotics is measured differently than its book value, which is the value of ReWalk that is recorded on the company's balance sheet. Investors also form their own opinion of ReWalk Robotics' value that differs from its market value or its book value, called intrinsic value, which is ReWalk Robotics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReWalk Robotics' market value can be influenced by many factors that don't directly affect ReWalk Robotics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReWalk Robotics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReWalk Robotics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReWalk Robotics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.